Board Meetings for WOCKPHARMA
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| WOCKPHARMA | Wockhardt Limited | 10 Nov 2016 | Results/Dividend | inter-alia, to consider & approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended September 30, 2016; issuance of Masala Bonds and declaration of interim dividend, if any. It is further informed that pursuant to Regulation 42 of the Listing Regulations, the Record Date for payment of interim dividend, if declared, will be November 19, 2016. Further, please note that pursuant to Company s code of conduct for regulating, monitoring, reporting trading by designated persons, the Trading window for dealing in the shares of the Company will be closed from October 29, 2016 to November 12, 2016 (both days inclusive). The Trading Window shall re-open with effect from November 13, 2016. | |
| WOCKPHARMA | Wockhardt Limited | 13 Aug 2016 | Results | Inter-alia, to consider & approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended June 30, 2016. | |
| WOCKPHARMA | Wockhardt Limited | 06 May 2016 | Results/Dividend | The Company had informed the Exchange regarding a meeting of the Board of Directors of the Company schedule to be held On May 06, 2016, inter-alia, to consider & approve the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended March 31, 2016; and issuance of Non-Convertible Debentures on private placement basis. The Company has now informed the Exchange that the Board of Directors of the Company at their meeting to be held on May 06, 2016 to inter-alia, consider recommendation of dividend on Preference Shares also.(Purpose Revised). | |
| WOCKPHARMA | Wockhardt Limited | 06 May 2016 | Results/Others | inter-alia, to consider & approve the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended March 31, 2016; and issuance of Non-Convertible Debentures on private placement basis. | |
| WOCKPHARMA | Wockhardt Limited | 11 Feb 2016 | Results | inter-alia, to consider and approve the Unaudited Financial Results (standalone and consolidated) of the Company for the quarter and nine months ended 31st December, 2015. | |
| WOCKPHARMA | Wockhardt Limited | 13 Nov 2015 | Results | Inter alia for the approval of unaudited financial results (consolidated and standalone) of the Company for the quarter and half year ended September 30, 2015. | |
| WOCKPHARMA | Wockhardt Limited | 10 Aug 2015 | Results | inter alia for the approval of unaudited financial results (consolidated and standalone) of the Company for the quarter ended June 30, 2015. | |
| WOCKPHARMA | Wockhardt Limited | 28 May 2015 | Results/Others | Inter-alia to consider the following items: 1) Approval of the Annual Audited Consolidated and Standalone Financial Statements of the Company for the year ended March 31, 2015 and Boards Report along with other Annexures, 2) Approval of the Audited Consolidated and Standalone financial results of the Company for the fourth quarter and year ended March 31, 2015 as per Clause 41 of the Listing Agreement and 3) Recommendation of dividend on Preference Shares, if any. | |
| WOCKPHARMA | Wockhardt Limited | 04 Feb 2015 | Results | Inter alia to consider and approve the unaudited financial results (consolidated and standalone) of the Company for the third quarter and nine months ended December 31, 2014. | - |
| WOCKPHARMA | Wockhardt Limited | 03 Nov 2014 | Results/Dividend | Inter-alia to consider and approve for following matters : 1. To consider and approve the Unaudited Financial Results (Consolidated and Standalone) of the Company for the second quarter and half year ended September 30, 2014. 2. To consider and recommend Interim Dividend, if any. | - |
| WOCKPHARMA | Wockhardt Limited | 15 Sept 2014 | Amalgamation/Merger | Inter alia to consider and approve amalgamation of two wholly owned subsidiaries viz Wockhardt Biopharm Limited and Vinton Healthcare Limited with Wockhardt Limited | |
| WOCKPHARMA | Wockhardt Limited | 12 Aug 2014 | Results | Inter alia, to consider and approve the unaudited financial results (consolidated and standalone) of the Company for the quarter ended June 30, 2014. Further, pursuant to Company's code for prevention of insider trading, the Trading window is closed from July 31, 2014 to August 13, 2014 (both days inclusive). The Trading Window shall re-open 24 hours after the financial results are submitted to the stock exchanges. | - |
| WOCKPHARMA | Wockhardt Limited | 26 May 2014 | Results/Dividend | 26-MAY-2014 : Inter alia, to consider and approve the following items:(1). Approval of the Annual Audited Consolidated and Standalone Accounts of the Company for the year ended March 31, 2014. (2). Approval of the Audited Consolidated and Standalone financial results of the Company for the quarter and year ended March 31, 2014.(3). Recommendation of dividend on preference shares.Further, pursuant to Company's code for prevention of insider trading, the Trading window is closed from May 14, 2014 to May 27, 2014 (both days inclusive). The Trading Window shall re-open 24 hours after the financial results and intimation of dividend are submitted to the stock exchanges | - |
| WOCKPHARMA | Wockhardt Limited | 09 Feb 2014 | Results/Dividend | Inter alia, for the following:(1) To consider and approve the unaudited financial results of the Company for the quarter and nine month ended December 31, 2013 .(2) Consideration of Interim Dividend. | - |
| WOCKPHARMA | Wockhardt Limited | 25 Oct 2013 | Results/Dividend | Inter alia, for the following:(1) To consider and approve the unaudited financial results of the Company for the quarter and half year ended September 30, 2013 .(2) Consideration of Interim Dividend. | - |